title: [Non-surgical treatment of hepatocellular carcinoma. An overview].
abstract: Surgery is often not a treatment option in patients with hepatocellular carcinoma with the numerous limitations of liver transplantation or surgical resection due to coexisting cirrhosis in the later case. Non-surgical treatments deal with 3 types of methods: local ablation with curative purpose, transarterial treatments with many technical variants and systemic treatment. Local treatments rely on chemical or thermic agents to achieve ablation of liver lesions, which not exceed initially 3 cm in diameter. The use of radiofrequency ablation allows now larger limits. Intra-arterial treatment usually combines intra-arterial chemotherapy with embolisation of hepatic artery in a procedure called chemoembolisation. Its antitumoral effect mainly due to ischemia is well documented but the influence on survival remains controversial. Finally systemic treatments have yet to be demonstrated useful: new agents and new randomised trials are still needed.
authors.affiliation: Service d'hépatogastroentérologie, hôpital Jean-Verdier, Assistance-publique-hôpitaux-de-Paris et UFR SMBH-université Paris-XIII, 93143 Bondy cedex, France. michel.beaugrand@jvr.aphp.fr
authors.forename: Michel
authors.initials: M
authors.lastname: Beaugrand
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Trinchet
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D017115:Catheter Ablation; D002986:Clinical Trials as Topic; D004621:Embolization, Therapeutic; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents